JPMORGAN CHASE & CO - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$879,147
+26.6%
19,814
+36.2%
0.00%
Q2 2023$694,474
+99.0%
14,547
+64.2%
0.00%
Q1 2023$349,000
+303378.3%
8,861
+117.3%
0.00%
Q4 2022$115
-99.9%
4,078
+4.0%
0.00%
Q3 2022$118,000
-9.2%
3,921
+2.1%
0.00%
Q2 2022$130,000
-72.5%
3,842
-63.6%
0.00%
Q1 2022$472,000
-39.0%
10,548
-37.1%
0.00%
Q4 2021$774,000
+145.7%
16,776
+79.2%
0.00%
Q3 2021$315,000
-26.4%
9,359
-35.7%
0.00%
Q2 2021$428,000
-29.6%
14,550
-38.3%
0.00%
Q1 2021$608,000
+4.5%
23,587
-7.6%
0.00%
Q4 2020$582,000
+70.7%
25,531
+58.2%
0.00%
Q3 2020$341,000
-15.8%
16,140
-7.5%
0.00%
Q2 2020$405,000
-43.2%
17,442
-47.8%
0.00%
Q1 2020$713,000
-34.9%
33,398
-28.7%
0.00%
Q4 2019$1,095,000
+99.1%
46,843
+79.0%
0.00%
Q3 2019$550,000
+63.2%
26,174
+55.8%
0.00%
Q2 2019$337,000
-67.7%
16,796
-54.8%
0.00%
Q1 2019$1,043,000
+19.7%
37,122
+4.3%
0.00%
Q4 2018$871,000
+2803.3%
35,604
+4290.1%
0.00%
Q3 2018$30,000
-65.5%
811
-80.7%
0.00%
Q2 2018$87,000
+33.8%
4,204
-8.7%
0.00%
Q1 2018$65,000
-42.5%
4,607
-38.1%
0.00%
Q4 2017$113,000
+5550.0%
7,444
+4552.5%
0.00%
Q3 2017$2,000
+100.0%
1600.0%0.00%
Q2 2017$1,000
-97.1%
160
-95.8%
0.00%
Q1 2017$34,000
-44.3%
3,814
-30.4%
0.00%
Q4 2016$61,000
+69.4%
5,480
+159.8%
0.00%
Q3 2016$36,0002,1090.00%
Other shareholders
IRADIMED CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders